Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancerBreast Cancer Res Treat 2022 Apr 26;[EPub Ahead of Print], ME Lacouture, SB Goldfarb, A Markova, SP Chawla, K Dewnani, M Iacobucci, JE Lang
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.